Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 4.80 is 41% above its 5-year average of 3.39, near the high end of its 5-year range (0.04–5.59).
As of the fiscal period ended Tuesday, June 30, 2026. 7.34% above its 12-month average of 4.47.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.80.
QUICK RATIO (ACID-TEST)
4.80
QUICK RATIO (ACID-TEST) AVG TTM
4.47
QUICK RATIO (ACID-TEST) AVG 3Y
4.50
QUICK RATIO (ACID-TEST) AVG 5Y
3.39
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+7.34%
CURRENT VS 3Y AVG
+6.67%
CURRENT VS 5Y AVG
+41.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.33
median of 858 covered companies
CURRENT VS SECTOR MEDIAN
+43.87%
vs the sector median at left
Market Cap
$634.07M
Quick Ratio (Acid-Test)
16.82
TTM Avg
9.46
3Y Avg
14.12
5Y Avg
14.05
Market Cap
$634.15M
Quick Ratio (Acid-Test)
2.55
TTM Avg
2.67
3Y Avg
4.11
5Y Avg
5.17
Market Cap
$629.45M
Quick Ratio (Acid-Test)
3.05
TTM Avg
5.21
3Y Avg
6.01
5Y Avg
5.25
Market Cap
$657.51M
Quick Ratio (Acid-Test)
1.15
TTM Avg
1.35
3Y Avg
1.35
5Y Avg
1.35
Market Cap
$617.87M
Quick Ratio (Acid-Test)
31.45
TTM Avg
23.29
3Y Avg
26.88
5Y Avg
23.21
Market Cap
$664.38M
Quick Ratio (Acid-Test)
5.53
TTM Avg
8.02
3Y Avg
10.47
5Y Avg
14.43
Market Cap
$666.78M
Quick Ratio (Acid-Test)
8.03
TTM Avg
12.16
3Y Avg
13.50
5Y Avg
14.42
Market Cap
$668.50M
Quick Ratio (Acid-Test)
10.97
TTM Avg
8.63
3Y Avg
10.75
5Y Avg
10.66
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OmniAb, Inc. (OABI) | $639.31M | 4.80 | 4.47 | 4.50 | 3.39 |
| Aura Biosciences, Inc. (AURA)vs › | $634.07M | 16.82 | 9.46 | 14.12 | 14.05 |
| SOPHiA GENETICS S.A. (SOPH)vs › | $634.15M | 2.55 | 2.67 | 4.11 | 5.17 |
| Prime Medicine, Inc. (PRME)vs › | $629.45M | 3.05 | 5.21 | 6.01 | 5.25 |
| Starling Oncology, Inc. (STLN)vs › | $657.51M | 1.15 | 1.35 | 1.35 | 1.35 |
| Climb Bio, Inc. (CLYM)vs › | $617.87M | 31.45 | 23.29 | 26.88 | 23.21 |
| Annexon, Inc. (ANNX)vs › | $664.38M | 5.53 | 8.02 | 10.47 | 14.43 |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $666.78M | 8.03 | 12.16 | 13.50 | 14.42 |
| Helus Pharma Inc. (HELP)vs › | $668.50M | 10.97 | 8.63 | 10.75 | 10.66 |
| MiMedx Group, Inc. (MDXG)vs › | $668.98M | 4.79 | 3.80 | 3.38 | 3.21 |
Quick Ratio
4.80
Excludes inventory
Current Ratio
4.80
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 4.80 |
| 2026-03-31 | 4.80 |
| 2025-12-31 | 4.02 |
| 2025-09-30 | 4.96 |
| 2025-06-30 | 3.77 |
| 2025-03-31 | 4.70 |
| 2024-12-31 | 4.52 |
| 2024-09-30 | 4.62 |
| 2024-06-30 | 4.75 |
| 2024-03-31 | 4.38 |
| 2023-12-31 | 4.11 |
| 2023-09-30 | 4.26 |
| 2023-06-30 | 4.78 |
| 2023-03-31 | 5.59 |
| 2022-12-31 | 4.80 |
| 2022-09-30 | 0.04 |
| 2022-06-30 | 0.55 |
| 2022-03-31 | 0.20 |
| 2021-12-31 | 1.10 |
| 2021-09-30 | 0.40 |
| 2021-06-30 | 0.06 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 1.17 |
| 2020-09-30 | 0.00 |
